Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    WEKA and Oracle Cloud Infrastructure Validate 10x Throughput Gains for Long-Context AI Inference

    June 9, 2026

    Beauty of Joseon Named ‘Global No.1 K-Beauty Suncare Brand in Online Sales’ by Euromonitor International

    June 9, 2026

    FAO backs $3.9bn GEF-9 funding for food security

    June 8, 2026
    Judaica JournalJudaica Journal
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Judaica JournalJudaica Journal
    Home » Cellebrite Announces Participation in Upcoming Investor Conferences
    PR Newswire

    Cellebrite Announces Participation in Upcoming Investor Conferences

    May 8, 2026
    Facebook Twitter Pinterest LinkedIn Telegram Tumblr Email

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 8, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions, today announced that the Company plans to participate in the following investor conferences in May and June:

    Cellebrite Logo

    Date:

    May 18, 2026

    Conference:

    J.P. Morgan 2026 Global Technology, Media and Communications Conference

    Presentation Time

    3:30 p.m. ET

    Format:

    Fireside Chat

    Cellebrite executive:

    Thomas Hogan, chief executive officer

    David Barter, chief financial officer

    Roni Fialkov, senior vice president, global finance

    Event URL:

    https://investors.cellebrite.com/events/event-details/jp-morgan-2026-global-technology-media-and-communications-conference

    Webcast URL:

    https://jpmorgan.metameetings.net/events/tmc26/sessions/318713-cellebrite-di-ltd/webcast/public

    Date:

    May 27, 2026

    Conference:

    TD Cowen 52nd Annual Technology, Media & Telecom Conference

    Presentation Time:

    11:25 a.m. ET

    Format:

    Fireside Chat

    Cellebrite executives: 

    David Barter, chief financial officer

    Andrew Kramer, vice president, investor relations

    Event URL:

    https://investors.cellebrite.com/events/event-details/td-cowen-annual-tmt-conference

    Webcast URL:

    https://event.summitcast.com/view/GSXkFLqLwmvLB7AnnUj3ti/guest_book?session_id=jr2gGDQmKRcqW3U3DaXeCT

    Date:

    May 28, 2026

    Conference:

    Craig-Hallum Institutional Investor Conference

    Format:

    1×1 Meetings Only

    Cellebrite executives: 

    David Barter, chief financial officer

    Andrew Kramer, vice president, investor relations

    Date:

    June 3, 2026

    Conference:

    William Blair 46th Annual Growth Conference

    Presentation Time:

    11:40 a.m. ET

    Format:

    Fireside Chat

    Event URL:

    https://investors.cellebrite.com/events/event-details/william-blair-46th-annual-growth-conference

    Webcast URL:

    https://event.summitcast.com/view/DTqswnj6gGSWZ7ywFcvpAo/guest_book?session_id=BXndAorr67BsBSqKdDpCQP

    Cellebrite executives: 

    David Barter, chief financial officer

    Andrew Kramer, vice president, investor relations

    Date:

    June 10, 2026

    Conference:

    Mizuho Technology Conference 2026

    Presentation Time:

    10:50 a.m. ET

    Format:

    1×1 Meetings Only

    Cellebrite executives: 

    David Barter, chief financial officer

    Andrew Kramer, vice president, investor relations

    Date:

    June 11, 2026

    Conference:

    D.A. Davidson 2026 Technology & Consumer Conference

    Format:

    1×1 Meetings Only

    Cellebrite executives: 

    David Barter, chief financial officer

    Andrew Kramer, vice president, investor relations

    Access to the webcasts for the fireside chats and management presentation is available in the events section within the Cellebrite investor relations microsite at https://investors.cellebrite.com/events-presentations.

    About Cellebrite 
    Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.

    Investors Relations
    Andrew Kramer
    Vice President, Investor Relations
    investors@cellebrite.com
    +1 973.206.7760

    Media 
    Victor Cooper
    Sr. Director of Corporate Communications + Content Operations
    Victor.cooper@cellebrite.com
    +1 404.804.5910

    Logo – https://mma.prnewswire.com/media/2855183/Cellebrite_Logo.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/cellebrite-announces-participation-in-upcoming-investor-conferences-302763028.html

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    WEKA and Oracle Cloud Infrastructure Validate 10x Throughput Gains for Long-Context AI Inference

    June 9, 2026

    Beauty of Joseon Named ‘Global No.1 K-Beauty Suncare Brand in Online Sales’ by Euromonitor International

    June 9, 2026

    Cellebrite Announces Upcoming Investor Events on June 10, 2026

    June 5, 2026

    Getac’s new 8-inch ZX80W and ZX80W-EX tablets blend Windows 11 functionality with energy-efficient fanless design, for all-day productivity in the field

    June 3, 2026

    Coupa Acquires Tonkean to Accelerate Agentic Intake and Orchestration for Global Trade

    May 21, 2026

    Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer

    May 20, 2026
    Breaking News

    FAO backs $3.9bn GEF-9 funding for food security

    June 8, 2026

    Egypt GDP rises 5.2% as foreign reserves climb

    June 8, 2026

    Korean cosmetics exports hit US$5.6 billion in five months

    June 8, 2026

    WHO reports 507 Ebola cases across Congo and Uganda

    June 8, 2026

    UN envoy cites regional push to end Middle East conflict

    June 6, 2026

    Global health bodies seek $518 million for Ebola response

    June 6, 2026

    Investor interest lifts UAE real estate in global index

    June 5, 2026

    Dollar heads for weekly gain as yen nears 160 level

    June 5, 2026
    © 2026 Judaica Journal | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.